Strategy
Starting in 2021, our strategy until 2026 is to digitize and improve microscopy workflows to provide diagnostic certainty in the world’s medical labs.
Our strategy rests on five pillars: dominate and set the next standard in large labs; drive rapid adoption in small/medium labs; fast-track reagents to global leadership, establish a sizable growth driver in the specialty analysis market, create winning businesses in new areas.